Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab.
Alashkar, Ferras
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab. [electronic resource] - Annals of hematology Apr 2017 - 589-596 p. digital
Publication Type: Journal Article
1432-0584
10.1007/s00277-017-2924-y doi
Adult
Aged
Aged, 80 and over
Animals
Antibodies, Monoclonal, Humanized--administration & dosage
Cohort Studies
Drug Administration Schedule
Female
Hemoglobinuria, Paroxysmal--blood
Humans
Male
Meningococcal Infections--blood
Meningococcal Vaccines--administration & dosage
Middle Aged
Rabbits
Retrospective Studies
Serologic Tests--methods
Serum Bactericidal Test--methods
Treatment Outcome
Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab. [electronic resource] - Annals of hematology Apr 2017 - 589-596 p. digital
Publication Type: Journal Article
1432-0584
10.1007/s00277-017-2924-y doi
Adult
Aged
Aged, 80 and over
Animals
Antibodies, Monoclonal, Humanized--administration & dosage
Cohort Studies
Drug Administration Schedule
Female
Hemoglobinuria, Paroxysmal--blood
Humans
Male
Meningococcal Infections--blood
Meningococcal Vaccines--administration & dosage
Middle Aged
Rabbits
Retrospective Studies
Serologic Tests--methods
Serum Bactericidal Test--methods
Treatment Outcome